| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 221 | Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders | US13901176 | 2013-05-23 | US08802077B2 | 2014-08-12 | Velerie Petit; Clara Garcia-Rodenas; Monique Julita; Guenolee Prioult; Annick Mercenier; Sophie Nutten |
| The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM 1-2618) for use in the treatment or prevention of disorders related to the immune system including infections. | ||||||
| 222 | Bifidobacterium longum NCC2705 (CNCM I-2618) and immune disorders | US13319649 | 2010-05-07 | US08784798B2 | 2014-07-22 | Valerie Petit; Clara Garcia-Rodenas; Monique Julita; Guenolee Prioult; Annick Mercenier; Sophie Nutten |
| The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defenses. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM 1-2618) for use in the treatment or prevention of disorders related to the immune system including infections. | ||||||
| 223 | Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients | US13319959 | 2010-05-11 | US08691244B2 | 2014-04-08 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the fields of hydration and nutrition for dysphagic patients. In particular, the present invention relates to thickeners comprising probiotic microorganisms and to compositions comprising such thickeners. The probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic microorganisms. | ||||||
| 224 | Anti-obesity agent and anti-obesity food | US13150558 | 2011-06-01 | US08637000B2 | 2014-01-28 | Hidetoshi Morita; Toshio Masaoka; Takehito Suzuki |
| An anti-obesity agent containing, as an active ingredient, a microorganism which belongs to the species Lactobacillus reuteri and is capable of producing lipases having the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5 or amino acid sequences having deletion, substitution or addition of one or more amino acids in the amino acid sequences respectively depicted in SEQ ID NO: 1, 3 or 5. The anti-obesity agent enables a patient to take a normal meal yet preventing the absorption of a fat into the body which is the primary cause of obesity. | ||||||
| 225 | ARRAY OF COMPLEMENTARY INFANT/YOUNG CHILD NUTRITIONAL COMPOSITIONS | US13885619 | 2011-10-25 | US20130280239A1 | 2013-10-24 | Petra Klassen; Corinne Magliola |
| The present invention relates to infant/young child nutrition. A set of nutritional compositions having beneficial effects to infants/young children is disclosed. The set of nutritional compositions comprises at least two compositions with varying amounts of components which impart a beneficial effect to the infants young/children. A nutrition kit for infants/young children comprising the set of nutritional compositions is also disclosed as well as a method for manufacturing the set of nutritional components. A dosage regimen is also disclosed. | ||||||
| 226 | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS | US13884543 | 2011-11-11 | US20130230611A1 | 2013-09-05 | Annick Mercenier; Antoine Wermeille; Audrey Demont; Guenolee Prioult |
| The present invention generally relates to the field of probiotic micro-organisms, in particular to the field of non-replicating probiotic micro-organisms. Embodiments of the present invention relate to compositions comprising probiotic micro-organisms that were rendered non-replicating by extrusion. Such compositions may be used to treat or prevent disorders that are related to a compromised immune system. | ||||||
| 227 | Use of lactic acid bacteria for improving food lysine absorption of pet animals | US12927459 | 2010-11-16 | US08496924B2 | 2013-07-30 | Eamonn Connolly; Bo Mollstam |
| This invention relates to the selection and use of nonpathogenic, lysine-uptake stimulating lactic acid bacteria strains, and products and methods using such strains for example for improvement of fur-coat and claws quality in pet-animals. | ||||||
| 228 | PRODUCTION AND USE OF BACTERIAL HISTAMINE | US13765947 | 2013-02-13 | US20130149291A1 | 2013-06-13 | James Versalovic; Carissa Michelle Thomas; Eamonn Connolly |
| A method is provided of selecting specific probiotic lactic acid bacteria producing histamine and the use of such strains for beneficial effects for mammals. The method includes selecting a lactic acid bacterial strain for use in the local production of histamine in a mammal, and further comprises screening bacteria for the presence of an. active histidine operon and selecting a strain which has an active histidine operon and is capable of producing histamine. Preferably said strain is selected for its ability to produce histamine at a level of greater than 250 pg/ml. The present invention further provides products comprising the strains obtainable by the selection methods of the invention for use in the local production, of histamine in a mammal, in particular for use in the treatment or prophylaxis of inflammatory conditions. | ||||||
| 229 | Dairy composition with probiotics and anti-microbial system | US12413784 | 2009-03-30 | US08349313B2 | 2013-01-08 | Gary Francis Smith; Alice Shen Cha; Zuoxing Zheng; Michael Gerard Roman; Benjamin Emanuel Dias |
| Dairy compositions are provided having a high pH, of about 4.8 to about 6.2, comprising desirable probiotic cultures as well as an anti-microbial system for inhibiting undesirable pathogenic and/or spoilage microbial growth without significantly reducing the beneficial effect of the probiotic cultures. | ||||||
| 230 | Indirect Substrates for Microorganisms Metabolizing 1,2-Propanediol | US13400735 | 2012-02-21 | US20120263696A1 | 2012-10-18 | Stefan ROOS |
| The present invention relates generally to enhanced activity of certain probiotics. The increased efficacy is achieved by using certain substrate components that indirectly supply the probiotics with a specific source of energy. The substrate components are specifically designed to stimulate 1,2-propanediol production. | ||||||
| 231 | PROBIOTIC CONTAINING MODULES FOR TUBE FEEDING | US13319941 | 2010-05-11 | US20120195867A1 | 2012-08-02 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of enteral nutrition to be administered via tube feeding. In particular, the present invention provides tube feeding modules comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | ||||||
| 232 | ORAL NUTRITIONAL SUPPLEMENT COMPRISING PROBIOTICS | US13319653 | 2010-05-11 | US20120183515A1 | 2012-07-19 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition. In particular, the present invention relates to the field of oral supplements. One embodiment of the present invention relates to the field of oral supplements comprising probiotics and/or bioactive non-replicating probiotics, for example heat treated probiotics. | ||||||
| 233 | INFANT CEREAL COMPRISING NON-REPLICATING PROBIOTIC MICROORGANISMS | US13319651 | 2010-05-11 | US20120183514A1 | 2012-07-19 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of infant cereals. In particular, the present invention relates to the field of infant cereals that can be used to strengthen the immune system of the infant and/or that can be used to treat or prevent inflammatory disorders. For example these benefits can be provided by probiotic micro-organisms. An embodiment of the present invention relates to an infant cereal comprising non-replicating probiotic-micro-organisms, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 234 | INSTANT THICKENER COMPRISING PROBIOTICS FOR HOT OR COLD FOODS AND BEVERAGES TO BE ADMINISTERED TO DYSPHAGIC PATIENTS | US13319959 | 2010-05-11 | US20120135044A1 | 2012-05-31 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the fields of hydration and nutrition for dysphagic patients. In particular, the present invention relates to thickeners comprising probiotic microorganisms and to compositions comprising such thickeners. The probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic microorganisms. | ||||||
| 235 | COMPLETE LIQUID NUTRITION FOR CHILDREN AT THE AGE OF 1-10 YEARS COMPRISING PROBIOTICS | US13319961 | 2010-05-11 | US20120121652A1 | 2012-05-17 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of nutrition for children. In particular, the present invention relates to the nutritional compositions intended for children with an impaired function of the gastro-intestinal tract. One embodiment of the present invention relates to a nutritional composition to be administered to children with an impaired function of the gastrointestinal tract comprising probiotic micro-organisms. The probiotic micro-organisms may be non-replicating, for example bioactive heat treated probiotic micro-organisms. | ||||||
| 236 | BIFIDOBACTERIUM LONGUM NCC2705 (CNCM I-2618) AND IMMUNE DISORDERS | US13319649 | 2010-05-07 | US20120114701A1 | 2012-05-10 | Valerie Petit; Clara Garcia-Rodenas; Monique Julita; Guenolee Prioult; Annick Mercenier; Sophie Nutten |
| The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of B. longum NCC2705 (deposit number CNCM I-2618) for use in the treatment or prevention of disorders related to the immune system including infections. | ||||||
| 237 | SPECIALIZED MEDICAL NUTRITION FOR SURGICAL AND TRAUMA PATIENTS CONTAINING PROBIOTICS | US13319953 | 2010-05-11 | US20120107287A1 | 2012-05-03 | Annick Mercenier; Sophie Nutten; Guenolee Prioult |
| The present invention relates to the field of specialized nutritional compositions. In particular, the present invention provides nutritional compositions for providing complete nutrition to hospitalized patients comprising probiotic micro-organisms. Such probiotic micro-organisms may be non-replicating micro-organisms, such as bioactive heat-treated probiotic micro-organisms, for example. | ||||||
| 238 | BACTERIAL COMPOSITIONS FOR PROPHYLAXIS AND TREATMENT OF DEGENERATIVE DISEASE | US13111105 | 2011-05-19 | US20110217368A1 | 2011-09-08 | Satya Prakash; Mitchell Lawrence Jones; Christopher Martoni |
| The disclosure provides an oral composition for reducing serum cholesterol, serum lipids, body fat, or atherogenic index or for prophylaxis or treatment of atherosclerosis, cardiovascular or cerebrovascular diseases, comprising a highly bsh active bacteria, isolate or supernatant thereof; wherein the highly bsh active bacteria degrades >50 μmol glycodeoxycholic acid (GDCA)/gram/hour and >2 μmol taurodeoxycholic acid (TDCA)/gram/hour when measured over 1 hour and 5 hours, respectively, or degrades >65 μmol GDCA/g/hr and >7 μmol TDCA/g/hr when measured over 30 minutes. | ||||||
| 239 | INCREASED FOLATE PRODUCTION LEVELS IN LACTOBACILLUS FERMENTING MELON JUICE | US12811782 | 2008-12-05 | US20110159148A1 | 2011-06-30 | Hendrikus Wegkamp; Filipe Branco De Santos; Eilt Johannes Smid; Jeroen Hugenholtz |
| The invention relates to the field of food, feed and food supplements comprising high folate levels, whereby the folate is produced by fermentation of Lactobacillus strains on melon fruit extract. Methods for increasing folate production of Lactobacillus strains are also provided. | ||||||
| 240 | Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter | US12657655 | 2010-01-25 | US07960137B2 | 2011-06-14 | Eamonn Connolly; Bo Mollstam |
| Strains of Lactobacillus which have been selected for their capability of reducing gastrointestinal inflammation, such as that due to Helicobacter pylori, and products derived from these strains, including agents for treatment or prophylaxis of inflammation associated with Helicobacter pylori for administration to humans and include conditioned media in which the selected strains have grown and protein-containing extracts of the conditioned media. | ||||||
QQ群二维码
意见反馈
意见反馈